Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma
- PMID: 15747747
- PMCID: PMC1280089
Von Hippel-Lindau gene deletion and expression of hypoxia-inducible factor and ubiquitin in optic nerve hemangioma
Abstract
Purpose: Von Hippel-Lindau (VHL) disease is a hereditary cancer syndrome expressed in multiple organs caused by germline alterations of the VHL gene. We have shown VHL deletion in the "stromal" cells of retinal angiomas. The VHL protein-associated complex is a primary ubiquitin ligase for the ubiquitination of hypoxia-inducible factor (HIF). This study examines VHL and ubiquitin expression in optic nerve hemangiomas and juxtapapillary angiomas.
Methods: Using microdissection and polymerase chain reaction, four optic nerve hemangiomas (one also had juxtapapillary angioma) associated with VHL disease were analyzed for loss of heterozygosity in the VHL gene. In addition, expression of HIF and ubiquitin was evaluated in these tumors by immunohistochemistry.
Results: All informative optic nerve and juxtapapillary lesions showed loss of heterozygosity in the VHL gene detected in vacuolated "stromal" cells. Both HIF and ubiquitin were highly expressed in the hemangiomas of all four VHL cases.
Conclusions: Like retinal angiomas and other VHL tumor lesions, VHL gene deletion is found in optic nerve hemangiomas and juxtapapillary angiomas. These tumor cells also express HIF and ubiquitin, the protein responsible for the negative regulation of HIF that results in the hypervascularization characteristic of VHL disease.
Figures






Similar articles
-
Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.Oncogene. 2000 Nov 16;19(48):5435-43. doi: 10.1038/sj.onc.1203938. Oncogene. 2000. PMID: 11114720
-
Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.J Neurosurg. 2004 Mar;100(3):488-97. doi: 10.3171/jns.2004.100.3.0488. J Neurosurg. 2004. PMID: 15035285
-
VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma.Arch Ophthalmol. 1999 May;117(5):625-30. doi: 10.1001/archopht.117.5.625. Arch Ophthalmol. 1999. PMID: 10326959
-
von Hippel-Lindau tumor suppressor: not only HIF's executioner.Trends Mol Med. 2004 Apr;10(4):146-9. doi: 10.1016/j.molmed.2004.02.004. Trends Mol Med. 2004. PMID: 15162797 Review.
-
The von Hippel-Lindau tumor suppressor gene.Exp Cell Res. 2001 Mar 10;264(1):117-25. doi: 10.1006/excr.2000.5139. Exp Cell Res. 2001. PMID: 11237528 Review.
Cited by
-
Internal en bloc resection and genetic analysis of retinal capillary hemangioblastoma.Arch Ophthalmol. 2007 Sep;125(9):1189-93. doi: 10.1001/archopht.125.9.1189. Arch Ophthalmol. 2007. PMID: 17846357 Free PMC article.
-
Hemangioblastoma of the optic nerve producing bilateral optic tract edema in a patient with von Hippel-Lindau disease.Surg Neurol Int. 2014 Mar 6;5:33. doi: 10.4103/2152-7806.128430. eCollection 2014. Surg Neurol Int. 2014. PMID: 24778921 Free PMC article.
-
Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease.Mol Vis. 2005 Sep 1;11:697-704. Mol Vis. 2005. PMID: 16163267 Free PMC article.
-
Pathology characteristics of ocular von Hippel-Lindau disease with neovascularization of the iris and cornea: a case report.J Med Case Rep. 2015 Mar 25;9:66. doi: 10.1186/s13256-015-0539-2. J Med Case Rep. 2015. PMID: 25885645 Free PMC article.
-
Ocular clusterin expression in von Hippel-Lindau disease.Mol Vis. 2007 Nov 15;13:2129-36. Mol Vis. 2007. PMID: 18079682 Free PMC article.
References
-
- Vortmeyer AO, Frank S, Jeong SY, et al. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease. Cancer Res. 2003;63:7051–7055. - PubMed
-
- Vortmeyer AO, Yuan Q, Lee YS, et al. Developmental effects of von Hippel–Lindau gene deficiency. Ann Neurol. 2004;55:721–728. - PubMed
-
- Cusik M., Dahr S, Srivastava S, et al. Intravitreal anti-VEGF therapy for advance ocular disease of von Hippel-Lindau (VHL) disease. ARVO, 2004.
-
- Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993;260:1317–1320. - PubMed
-
- Melmon KL, Rosen SW. Lindau’s disease: review of the literature and study of a large kindred. Am J Med. 1964;36:595–617. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical